Past Presentations

2023

 

229. Bode L (2023) Human Milk-Oligosaccharide-Based Therapeutics and Diagnostics
to Protect Preterm Infants from Necrotizing Enterocolitis. Invited Speaker, College of Lactation Consultants Western Australia Biennial Conference "Milking the Evidence", Perth Australia.

 

228. Bode L (2023) From Molecules to Systems: A New Area of Human Milk Research. Invited Keynote Speaker, College of Lactation Consultants Western Australia Biennial Conference "Milking the Evidence", Perth Australia.

 

227. Bode L (2023) Determinants and potential benefits of Human Milk Oligosaccharides. Invited Speaker, ABREAST Conference, Perth, Australia.

 

226. Bode L (2023) Human Milk and Why it Matters. Invited Speaker, CHOC 21st Academic Day for Neonatologists, Anaheim, CA, USA.

 

225. Bode L (2023) The Power of Human Milk (Oligosaccharides). Invited Keynote Speaker, Annual Ontario NICU Registered Dietitian Meeting, Toronto, Canada. (online)

 

224. Bode L (2023) The Effects of HMOs on Gut Health and Human Nutrition. Invited Speaker, 14th Asian Congress of Nutrition, Chengdu, China.

 

223. Bode L (2023)  Human milk-based therapeutics and diagnostics to reduce NEC. Invited Speaker, NEC Symposium, San Diego, CA, USA.

 

222. Bode L (2023) The Power of Human Milk Oligosaccharides. Kyowa Hakko Bio - HMO Science Forum, 2nd Symposium. Invited Speaker, Tokyo, Japan.

 

221. Bode L (2023) Lactation as a Biological System: The dynamics of human milk composition. Advancing Lactation Science to Improve Care - Breastfeeding & Lactation Symposium Series 2023, Munich, Germany.

 

220. Bode L (2023) Human Milk (Oligosaccharides) at the Interface of Maternal-Infant-Health. Invited Speaker, EISL Congress, Munich, Germany.

 

219. Bode L (2023) Endogenous and Exogenous Glycans as Drivers of Early Life Microbial Communities and Health. Invited Speaker and Session Chair, 5th FASEB Science Research Conference on Origins and Benefits of Biologically Active Components in Human Milk, Melbourne, FL, USA.

 

218. Bode L (2023) Lactation as a Biological System: The dynamics of human milk composition. Advancing Lactation Science to Improve Care - Breastfeeding & Lactation Symposium Series 2023, Beijing, China.

 

217. Bode L (2023) What’s New in the Science of HMO: New Research and Future Direction. Invited Speaker, ESPGHAN 55th Annual Meeting, Vienna, Austria.

 

216. Bode L & Niels Banke (2023) Importance of Human Milk Oligosaccharides in Early Life Nutrition: Opportunities for innovation with HMOs. Invited Panelist, ESPGHAN 55th Annual Meeting, Vienna, Austria.

 

215. Bode L (2023) Oligosacáridos de leche humana - Human Milk Oligosaccharides. Invited Speaker, 2nd Congreso Internacional de Lactancia Materna, Santiago, Chile. (remote)

 

214. Bode L (2023) Human milk-based therapeutics and diagnostics to protect pretrm babies from necrotizing enterocolitis. Invited speaker, Inaugural Sanford Children’s Health Research Center Scientific Symposium Children’s Diseases: Models and Therapy, La Jolla, CA, US.

 

213. Bode L (2023) HMI and HMOs. Invited keynote speaker, 12th Annual Pediatric Research Symposium, UC San Diego, La Jolla, CA, US. 

 

212. Bode L (2023) Embedding and Enabling Human Milk Research in NICHD networks. 2nd Annual MPRINT meeting, La Jolla, CA, US.

 

211. Bode L (2023) Lactation as a Biological System: The dynamics of human milk composition. Advancing Lactation Science to Improve Care - Breastfeeding & Lactation Symposium Series 2023, Chicago, IL, US.

 

210. Bode L (2023) Recent Discoveries on Human Milk Oligosaccharide Biosynthesis and Function. San Diego Glycobiology Symposium, La Jolla, CA, US.

 

209. Bode L (2023) The Human Milk Institute: A Vision for the Future of Human Milk. Uc San Diego Human Milk Institute Launch & Symposium, La Jolla, CA, US.

 

208. Bode L (2023) Role of Human Milk Oligosaccharides in Preterm Infant Nutrition. Invited Speaker, 2023 Preterm Nutrition and Growth (PNG) Conference, Pasadena, CA, US.

 

207. Bode L (2023) Endogenous and Exogenous Glycans as Drivers of Early-Life Microbial Communities and health. Invited Speaker, Center for Microbiome Innovation International Microbiome Meeting (CIMM), La Jolla, CA, US 

 

206. Bode L (2023) Developing therapeutics and diagnostics for NEC based on human milk. MPRINT Webinar.

 

205. Bode L (2023) Human Milk Oligosaccharides: Opportunities for targeted pre-, pro-, and synbiotics for people of all ages. Invited Speaker, IPA World Congress and Probiota 2023, Barcelona, Spain.

 

204. Bode L (2023) Human Milk (Oligosaccharides) at the Interface of Maternal-Infant Health. Invited Speaker. Pediatrics Grand Rounds, Oklahoma Children's Hospital. Oklahoma City, OK. 

2022

 

203. Bode L (2022) Human Milk (Oligosaccharides) at the Interface of Maternal-Infant Health. Invited Speaker. UC San Diego Center for Perinatal Discovery Monthly Seminar, La Jolla, CA, USA. 

 

202. Bode L (2022) COVID-19 an Human Milk - Are we prepared for the next pandemic? Invited Speaker, More Than Milk Lactation Science Symposium, University of Western Australia, Perth, Australia. 

 

201. Bode L (2022) Human Milk (Oligosaccharides) at the Interface of Maternal-Infant Health. Invited Speaker, SIBEN (Iberoamerican Society of Neonatology), Merida, Mexico.

 

200. Bode L (2022) Human Milk Oligosaccharides at the Interface of Maternal-Infant Health - and Beyond... Invited Speaker, 3rd International Conference on Food Bioactives & Health, Parma, Italy.

 

199. Bode L (2022) Human Milk Oligosaccharides at the Interface of Maternal-Infant Health. 32nd Annual Conference on Breastfeeding, Emory University, Atlanta. [Online Conference]

 

198. Bode L (2022) Human milk, Maternal and Pediatric Therapeutics, and Pandemic Readiness. 32nd Annual Conference on Breastfeeding, Emory University, Atlanta. [Online Conference]

 

197. Bode L (2022) Human Milk (Oligosaccharides) at the Interface of Maternal and Infant Health. Annual Conference, Metabolic Health Center Maternal and Child Health, Stanford University. [Online Conference]

 

196. Bode L (2022) Human Milk at the Intersection of Maternal and Pediatric Therapeutics. MPRINT webinar. [Online Webinar]

2021

 

195. Bode L (2021) Human Milk (Oligosaccharides) at the Intersection of Maternal and Infant Health. Brigham and Women's Hospital Pediatric Newborn Medicine Grand Rounds. [Online Grand Rounds]

 

194. Bode L (2021) Consideration of Interactions between Bioactive Ingredients. Invited Speaker. NIH/FDA Workshop on Bioactive Ingredients in Infant Formula. [Online Workshop]

 

193. Bode L (2021) Safety Evaluation of Human Milk at the Onset of the COVID-19 Pandemic. Invited Speaker. 15th Global Breastfeeding & Lactation Symposium. [Global Online Conference] 

 

192. Bode L (2021) HMOs: An Innovation that is Revolutionizing Infant Nutrition. Invited Speaker. LATAM Virtual Seminars for Pediatric Nutrition, Colombia. [Online Seminar Series for Latin America]

 

191. Bode L (2021) COVID-19 - Human Milk research and Immunity. Invited Speaker. International Congress of Dietetics (ICD) 2021, South Africa. [Global Online Conference]

 

190. Bode L (2021) An Introduction to Human Milk Oligosaccharides. Invited Speaker. Massey University Nutrition Update, New Zealand. [Online Seminar Series]

 

189. Bode L, Aghaeepour N, Becker, M (2021) ‘Omics’ and Machine Learning Tools to Understand the Mother-Milk-Infant Triad. Invited Speaker. 20th Conference of the International Society for Research in Human Milk and Lactation (ISRHML). [Global Online Conference]

 

188. Bode L (2021) Overview of Human Milk Science. Invited Speaker and Conferenve Co-Chair. 4th FASEB SRC on "Origins and Benefits of Biologically Active Components in Human Milk". [Online Conference]

 

187. Bode L (2021) COVID and Human Milk Research. Invited Speaker and Conferenve Co-Chair. 4th FASEB SRC on "Origins and Benefits of Biologically Active Components in Human Milk". [Online Conference]

 

186. Bode L (2021) Bioactive Components in Human Milk. Invited Speaker. World Congress of Pediatric Gastroenterology, Hepatology and Nutrition. [Global Online Symposium]

 

185. Bode L (2021) Human Milk Oligosaccharides: What they are and what they do. Invited Speaker and Conference Co-Chair. 96th Nestle Nutrition Workshop. Strategies in neonatal care to promote optimized growth and health: Focus on low birth weight infants. [Global Online Symposium]

 

184. Bode L, van Goudouever H (2021) SARS-CoV-2, IgA antibodies and human milk: What is the latest evidence? Invited Speaker. Nutricia Global Virtual Conference: Impacting Health in the New Norm with Specialized Nutrition. [Global Online Conference]

 

183. Bode L (2021) Human Milk Oligosaccharides: The Old and New Frontier. Invited Speaker. Nutricia Global Virtual Conference: Impacting Health in the New Norm with Specialized Nutrition. [Global Online Conference]

 

182. Bode L (2021) Human Milk Oligosaccharides: Next-Generation Functions and Questions. Invited Speaker. The 8th Bebeficial Microbes Conference. [Webinar]

 

181. Bode L (2021) Basic Science and Complexity of Human Milk Oligosaccharides. Invited Speaker. Research Seminar, University of California San Francisco, San San Francisco, CA, USA. [Webinar]

 

180. Bode L (2021) Human Milk Oligosaccharides: Recent Advances and Discoveries. Invited Speaker. Bramham Pediatric Nutrition Lecture - Pediatric Grand Rounds, University of California San Francisco, San San Francisco, CA, USA. [Webinar]

2020

 

179. Bode L (2020) The Power of Human Milk (Oligosaccharides). Invited Speaker. Gastroenterology Research Seminar, Department of Medicine, University of California San Diego, San Diego, CA, USA. [Webinar]

 

178. Bode L (2020) The Power of Human Milk (Oligosaccharides). Invited Speaker. Pediatric Grand Rounds, Rady Childrens Hospital San Diego & University of California San Diego, San Diego, CA, USA. [Webinar]

 

177. Bode L (2020) The Potential of Human Milk Oligosaccharides (HMOs): What they are and what they do. Invited Symposium Speaker. Spanish Pediatric Association Congress, Spain. [Webinar]

 

176. Bode L (2020) The Power of Human Milk (Oligosaccharides). Invited Speaker. Pediatric Grand Rounds, New York Medical College, NY, USA. [Webinar] 

 

175. Bode L (2020) The Current and Future Potential of Human Milk Oligosaccharides (HMOs) in Neonatology. Invited Symposium Speaker. 46th Jahrestagung der Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin, Germany. [Webinar]

 

174. Bode L (2020) Human Milk Oligosaccharides (HMOs): Impact on Maternal and Infant Health and Development. Invited Speaker. Biostime Institute of Nutrition and Care (BINC), Geneva, Switzerland. [Webinar]

 

173. Bode L (2020) Human Milk Oligosaccharides (HMOs) for Immune System Development. Invited Symposium Speaker. The European Academy of Allergy and Clinical Immunology (EAACI)-Food Allergy and Anaphylaxis (FAAM) Meeting, Digital Meeting. [Webinar]

 

172. Bode L (2020) The Importance and Benefits of Human Milk Oligosaccharides. Invited Speaker. The European Foundation for the Care of Newborn Infants (EFCNI). [Webinar]

 

171. Bode L (2020) Human Milk Oligosaccharides - The Magic Sugars in Mom's Breastmilk. Invited Keynote Speaker. Giessen Graduate Center for the Life Sciences (GGL), Justus-Liebig-University, Giessen, Germany. [Webinar]

 

170. Bode L (2020) Frontline Research: Human Milk and Lactation during the COVID-19 Crisis - Breastmilk in a Time of Contagion. Invited Speaker. Center for Health Equity, Education, & Research, Mississippi Communities and Hospitals Advancing Maternity Practices (CHAMPS), Boston Medical Center, Boston, MA, USA. [Webinar]

 

169. Bode L (2020) The Power of Human Milk Oligosaccharides. Invited Speaker. San Diego County Breastfeeding Coalition, San Diego, CA, USA. [Webinar]

 

168. Bode L (2020) The Power of Human Milk Oligosaccharides. Invited Speaker. Grand Rounds, Children’s Hospital of Philadelphia (CHOP), Philadephia, PA, USA. [Webinar]

 

167. Bode L (2020) Medela Roundtable on COVID-19 and Human Milk. Invited Speaker. [Webinar]

 

166. Bode L (2020) COVID-19 and Human Milk. What do we know. Invited Speaker. Medela Education and Clinical Services. [Webinar]

 

165. Bode L (2020) Human Milk Oligosaccharides and Interactions with the Gut Microbiome. Invited Speaker. ILSI North America 2020 Annual Meeting & Science Symposium in Washington, DC, USA. [Webinar]

 

164. Bode L (2020) The Science of Human Milk Oligosaccharides: What they are and what they do. Invited Symposium Speaker. 6th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition (WCPGHAN2020). Copenhagen, Denmark. [Webinar]

 

163. Bode L  (2020) Human Milk Oligosaccharides: Maternal Drivers and Infant Outcomes. Invited Speaker, 2020 Ved Londghe State-of-the Art lecture. Western Society for Pediatric Research Conference, Carmel, CA, USA.

2019

 

162. Bode L (2019) Human Milk Oligosaccharides: Maternal Drivers and Short- and Long-Term Health. Invited Speaker. 1st UC San Diego Human Milk Research Symposium, La Jolla, CA, USA.

 

161.  Bode L (2019) Human Milk Oligosaccharides at the Interface of Maternal and Infant Health. Invited Speaker. National Association of Neonatal Nurses - Southern California Chapter, San Diego, CA, USA.

 

160.  Bode L (2019) Human Milk Oligosaccharides at the Interface of Maternal and Infant Health. Invited Speaker. American Academy of Pediatrics (AAP) National Conference, New Orleans, LA, USA.

 

159.  Bode L (2019) Human Milk Oligosaccharides and their effects on infant health and development. Invited Speaker. 39th Brazilian Pediatric Society Congress, Porto Alegre, Brazil.

 

158.  Bode L (2019) Human Milk Oligosaccharides: Impact on Microbiota and Infant Outcomes. Invited Speaker. 5th European Milk Bank Association Congress, Turin, Italy.

 

157.  Bode L (2019) Human Milk Oligosaccharides and their Effects on Infant Health and Development. Invited Speaker. 25th Italian National Society for Neonatology Congress, Catania, Italy.

 

156.  Bode L (2019) Human Milk Oligosaccharides: Structure & Function. Invited Speaker. 94th Nestle Nutrition Institute Workshop, Lausanne, Switzerland.

 

155.  Bode L (2019) Breastfeeding: Why Every Baby Needs a Sugar Mama. Invited Speaker. American Academy of Pediatrics - Orange County Chapter, "Sugar" conference, Orange County, CA, USA.

 

154.  Bode L (2019) Human Milk Oligosaccharides for Infants and Adults. Invited Speaker. FASEB Science Research Conference, Origins and Benefits of Human Milk Bioactives, West Palm Beach FL, USA.

 

153.  Bode L (2019) Human Milk Oligosaccharides as Primers of the Microbiome and Immune System. Invited Speaker, ESPGHAN Congress, Glasgow, Scotland.

 

152.  Bode L (2019) What is the Role of Oligosaccharides in Neonatal Disease? Invited Speaker. Academy of Neonatal Nursing Conference, Palm Springs, CA, USA.

 

151.  Bode L (2019) Benefits of Human Milk and the Role of Oligosaccharides. Invited Speaker. Academy of Neonatal Nursing Conference, Palm Springs, CA, USA.

 

150.  Bode L (2019) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker. 2019 Perinatal Symposium, Tri-City Medical Center, Oceanside, CA, USA.

 

149.  Bode L (2019) Power of Human Breast Milk - For Babies and Adults. Invited Speaker. 2019 UC San Diego Vice-Chancellor Spring Symposium. La Jolla, CA, USA.

 

148.  Bode L (2019) Human Milk Oligosaccharides in Short- and Long-Term Health and Development. Invited Speaker. International Pediatric Association Congress, Panama City, Panama.

 

147.  Bode L (2019) Introduction to the Basic Science and Complexity of Human Milk Oligosaccharides. Nutrition & Growth Conference, Valencia, Spain.

 

146.  Bode L (2019) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Children’s Hospital Research Institute Manitoba & Devotion Network. Research Rounds. Winnipeg, Manitoba, Canada.

 

145.  Bode L (2019) Human Milk Oligosaccharides: Update from the Bode Lab. Invited Speaker. San Diego Glycobiology Symposium, San Diego, CA, USA.

 

144.  Bode L (2019) Human Milk Oligosaccharides: Prebiotics and Beyond. Arkansas Children's Nutrition Center. Research Rounds. Invited Speaker. Little Rock, AR, USA.

2018

143. Bode L (2018) Learning from Mother Nature: Human Milk Oligosaccharides as novel therapeutics in infants and adults. UC San Diego School of Medicine PRISM Lecture. La Jolla, CA, USA.

 

142. Bode L (2018) Human Milk Oligosaccharides: Every Baby Needs A Sugar Mama. 23rd Annual International Meeting, Academy of Breastfeeding Medicine, Invited Keynote Speaker, 13th Annual Founders' Lecture. San Francisco, CA, USA.

 

141. Bode L (2018) Human Milk Oligosaccharides: Benefits for the breastfed baby and beyond. 7th Congress of the European Academy of Paediatric Societies (EAPS 2018). Invited Speaker. Paris, France.

 

140. Bode L (2018) Human Milk Oligosaccharides: Maternal Drivers and Infant Outcomes. 19th Conference of the International Scoiety for Research in Human Milk and Lactation. Invited Speaker. Kanagawa, Japan.

 

139. Bode L (2018) Human Milk Oligosaccharides: From Necrotizing Enterocolitis in Preterm Infants to Frailty in the Elderly. 2nd GlycoCom and 1st Human Glycome Project Meeting. Invited Keyntote Speaker. Dubrovnik, Croatia.

 

138. Bode L (2018) Development of an Objective Biomarker of Breastfeeding. Wellcome Trust Collection. Invited Speaker. London, UK.

 

137. Bode L (2018) Basic Science and Complex Biology of Human Milk Oligosaccharides. Nutrition 2018, American Society for Nutrition Annual Meeting. Invited Speaker. Boston, MA, USA. 

 

136. Bode L (2018) Human Milk Oligosaccharides at the Interface of Maternal-Infant Health. San Diego Midwifery Conference, "Midwives, Mamas and More". Invited Speaker. San Diego, CA, USA.

 

135. Bode L (2018) Immediate and Potential Long-Term Effects of Human Milk Oligosaccharides. 9th Annual Pediatric Research Symposium - UC San Diego and Rady Childrens Hospital San Diego. Invited Speaker. San Diego, CA, USA.

 

134. Bode L (2018) Human Milk Oligosaccharides at the Interface of Maternal-Infant Health. Pediatric Academic Societies (PAS) Meeting. Invited Speaker. Toronto, Canada.

 

133. Bode L (2018) Human Milk Oligosaccharides at the Interface of Maternal-Infant Health. 7th International Congress on Donor Human Milk Banking, organized by the Human Milk Banking Association of North America (HMBANA). Invited Speaker. Denver, CO, USA.

 

132. Bode L (2018) Human Milk Oligosaccharides as primers for infant and long-term health. 7th Workshop of the inFLAME Global Network. Invited Speaker. Canmore, Canada.

 

131. Bode L (2018) Human Milk Oligosaccharides at the host-microbial interface and beyond. UC San Diego Center for Microbiome Innovation, Monthly Seminar. Invited Speaker. La Jolla, CA, USA.

 

130. Bode L (2018) Human Milk Oligosaccharides at the Interface of Maternal-Infant Health. Hong Kong Argyle Study Group. Invited Speaker. Hong Kong.

 

129. Bode L (2018) Human Milk Oligosaccharides and Neonatal Immunity. Hong Kong Sanatorium and Hospital. Invited Speaker. Hong Kong.

 

128. Bode L (2018) Human Milk Oligosaccharides at the Interface of Maternal-Infant Health. Hong Kong PPP. Invited Speaker. Hong Kong.

 

127. Bode L (2018) Human Milk Oligosaccharides and Neonatal Immunity. Hong Kong Paediatric Foundation. Invited Speaker. Hong Kong.

 

126. Bode L (2018) Human Milk Oligosaccharides and Necrotizing Enterocolitis. NEO 2018 - The Neonatology Conference. Orlando, FL, USA.

 

125. Kim JH, Stellwagen L, Chambers C, Bode L (2018) The Milky Way Constellation at UC San Diego Health. Rady Children's Hospital San Diego, Grand Rounds. Invited Speaker. San Diego, CA, USA.

 

124. Bode L (2018) Human Milk Oligosaccharides shape microbial communities early in life with potential health implications throughout the life cycle. San Diego Microbiology Group. Research Seminar. Invited Speaker. La Jolla, CA, USA.

Presentations prior to 2018

 

98.  Bode L  (2016) Novel Clinical Nutrition Strategies for Diegstive Health. Invited Speaker, 24th Annual World Congress on Anti-Aging Medicine, Hollywood, FL, USA.

 

97.  Bode L  (2016) Human milk oligosaccharides contribute to shaping the microbiome early in life. Invited Speaker, 7th Annual Pediatric Faculty Research Symposium, University of California, San Diego, San Diego, CA, USA.

 

96.  Bode L  (2016) Combining preclinical models with mother-infant cohort studies to unravel the benefits of human milk oligosaccharides. Invited Speaker, 11th International Breastfeeding and Lactation Symposium, Berlin, Germany.

 

95.  Bode L  (2016) Specialized Prebiotics to Support Health Outcomes. Invited Speaker, University of Miami, Advances in Clinical Practices for Chronic Conditions, Miami, FL, USA.

 

94. Bode L (2016) Biosynthesis and Functions of Human Milk Oligosaccharides. Invited Speaker. San Diego Glycobiology Symposium, San Diego, CA, USA.

 

93. Bode L (2016) Human milk oligosaccharides as early predictors and potential therapeutics of obesity. Invited Speaker, 18th Conference, International Society for Research in Human Milk and Lactation, Stellenbosch, South Africa.

 

92. Bode L (2016) The power of human cohort studies: Closing the gap between preclinical models and clinical intervention studies. Invited Speaker, 18th Conference, International Society for Research in Human Milk and Lactation, Stellenbosch, South Africa.

 

91. Bode L  (2016) Learning from Mother Nature: Human Milk Oligosaccharides as therapeutics for infants and adults. Invited Speaker, Research Seminar, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA.

 

90.  Bode L  (2015) Back to the future of human milk oligosaccharides. Invited Speaker, University of Zurich, Vision 2020 Lecture, Zurich, Switzerland.

 

89.  Bode L  (2015) The functional biology of human milk oligosaccharides. Invited Speaker. Neonatal Update 2015, "the science of newborn care", London, UK.

 

88. Bode L  (2015) Dietary Effects on the Microbiome: Learning from Mother Nature. Invited Speaker. Nutrition Pro 2015: Medical Nutrition Therapy in Practice, Orlando, FL, USA.

 

87. Bode L  (2015) Oligosaccharides in Human Milk and their contributions to neonatal health and disease. Invited Speaker. California Association of Neonatologists (CAN), California NICU Medical Directors Meeting, Los Gatos, CA, USA.

 

86.  Bode L  (2015) Effects of the Microbiome on Immunity. What determines the microbiome early in life? An Introduction to Human Milk Oligosaccharides. Invited Speaker. AABB Annual Meeting, Anaheim, CA, USA.

 

85.  Bode L  (2015) A Research Update on Human milk oligosaccharides. Invited Speaker. Research Seminar, UCSD Pediatric Gastroenterology, Hepatology and Nutrition, San Diego, CA, USA.

 

84.  Bode L  (2015) Human milk oligosaccharides: Lessons learned from basic science research for outcomes affecting the infant in the developing. Invited Speaker. 1st Human Milk and Lactation Symposium: From Bench to Lebanese Baby, Notre Dame University-Zouk Mosbeh, Beirut, Lebanon.

 

83.  Bode L  (2015) An Introduction to Human Milk Oligosaccharides. Invited Speaker. FASEB SRC - Origins and Benefits of Biologically Active Components in Human Milk. Big Sky, MT, USA.

 

82.  Bode L  (2015) Human Milk Oligosaccharides in the Prevention of Necrotizing Enterocolitis. Invited Speaker. Pediatric Grand Rounds. Betty H. Cameron Women's and Children's Hospital, New Hanover Regional Medical Center, NC, USA.

 

81.  Bode L  (2015) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker. Coastal Carolina Neonatology, Dinner Keynote Lecture. Wilmington, NC, USA.

 

80. Bode L (2015) Human Milk Oligosaccharides as primers of the infant microbiome. Invited Speaker. Old Herborn University Seminar, Herborn, Germany.

 

79. Bode L (2015) Human Milk Oligosaccharides and their Benefits for Infants. Invited Speaker. BINC - Biostime Institute of Nutrition and Care, Hangzhou, China.

 

78. Bode L (2015) Human Milk Oligosaccharides: Natural Prebiotics and Beyond. Invited Speaker. Metagenics Educational Seminar Series, Austin, TX, USA.

 

77. Bode L (2015) Human Milk Oligosaccharides: The Power of Cohort Studies. Invited Speaker. Grand Rounds, UCSD Department of Medicine, Division of Gastroenterology, San Diego, CA, USA.

 

76. Bode L (2015) Perinatal Nutrition and Metabolism Club: Human Milk Oligosaccharides: Influences on Neonatal Health and Disease. Pediatric Academic Societies (PAS) Meeting, San Diego, CA, USA.

 

75. Bode L (2015) Interactions between breastmilk oligosaccharides and mother/infant microbiome. Invited Speaker. International Human Microbiome Consortium (IHMC) Congress, Luxemburg.

 

74. Bode L (2015) Human Milk Oligosaccharides as direct and indirect primers of the infant microbiome. Invited Speaker. Gordon Research Conference - Glycobiology, Lucca (Barga), Italy.

 

73. Bode L (2015) Biosynthesis and Functions of Human Milk Oligosaccharides. Invited Speaker. San Diego Glycobiology Symposium, San Diego, CA, USA.

 

72. Bode L (2014) Introduction to Microbiome Glycomics. Workshop Co-chair and Speaker. Society for Glycobiology, Annual Meeting, Honolulu, Hawaii, USA.

 

71. Bode L (2014) Human Milk Oligosaccharides as Primers for the Infant Gut. Invited Speaker. 17th Conference of the International Society for Research in Human Milk and Lactation, Kiawah Island, SC, USA.

 

70. Bode L (2014) Benefits of Human Milk Oligosaccharides for the Breastfed Infant. Invited Speaker. 2nd Annual International Conference on Human Milk Science & Innovation. Santa Monica, CA, USA.

 

69.  Bode L  (2014) Functionality of Human Milk Oligosaccharides. Invited Speaker, Research Seminar. Wageningen University, The Netherlands.

 

68.  Bode L (2014) Functionality of Milk Oligosaccharides: Only the Tip of the Sugarloaf? Invited Speaker. 7th International Whey Conference, Rotterdam, The Netherlands.

 

67.  Bode L (2014) Human milk oligosaccharides as natural drug templates. Invited Speaker, Research Seminar. Technical University Munich, Munich, Germany.

 

66.  Bode L (2014) Milch Oligosaccharide und die Symbiose von Mutter, Kind und Bakterien. [German] Invited Speaker. 40th Annual Meeting of the Society for neonatology and pediatric intensive care medicine, Bonn, Germany.

 

65.  Bode L (2014) Milk Oligosaccharides. Invited Speaker. National Institutes of Health, “Exploring the Frontiers of Chemical Glycoscience”, Bethesda, MD, USA.

 

64.  Bode L (2014) Human Milk Oligosaccharides: The Role of Breast Milk Prebiotics in Selecting the Infant Microbiome. Invited Speaker. DDW - Digestive Disease Week, Chicago, IL, USA.

 

63.  Bode L (2014) Sialylated Oligosaccharides in Human Milk and their Role in Infant Physiology and Disease Prevention. Invited Speaker, EB - Experimental Biology, San Diego, CA, USA.

 

62.  Bode L (2014) An Introduction to Human Milk Oligosaccharides and their Potential Benefits for the Breastfed Infant and the Breastfeeding Mother. Invited Speaker, EB - Experimental Biology, San Diego, CA, USA.

 

61.  Bode L (2014) Oligosaccharides in Human Milk. Invited Speaker, Research Seminar, Stellenbosch University, Stellenbosch/Cape Town, South Africa.

 

60.  Bode L (2014) Human Milk Oligosaccharides: An Update from the Milk Gang. Invited Speaker. San Diego Glycobiology Symposium, San Diego, CA, USA.

 

59.  Bode L (2014) Oligosaccharides and Nutrition. Invited Speaker. NEO - The Conference for Neonatology, Orlando, FL, USA.

 

58.  Bode L (2014) Human Milk Oligosaccharides: Every Baby needs a Sugar Mama. Invited Speaker, Research Seminar, Complex Carbohydrate Research Center (CCRC), University of Georgia, Athens, GA, USA. 

 

57.   Bode L (2014) Natural protection: Human milk oligosaccharides in the prevention of infectious diseases. Invited Speaker. Pediatric Infectious Disease Conference, University of California, San Diego, CA, USA.

 

56.  Bode L (2013) Human Milk Oligosaccharides: An Update from the Milk Gang. Invited Speaker, Hillcrest Biomedical and Clinical Research Seminar, University of California, San Diego, San Diego, CA, USA.

 

55.  Bode L (2013) Forschung aktuell: Oligosaccharide in der Muttermilch [German]. Invited Speaker, 8th Deutschen Still- und Laktationskongress - 8th German Breastfeeding and Lactation Conference, Freie Universitaet Berlin, Berlin, Germany.

 

54.  Bode L (2013) Human Milk Oligosaccharides: Why Glycans Matter”. Invited Speaker, Children’s Hospital Los Angeles, The Saban Research Institute, Research Seminar, Los Angeles, CA, USA.

 

53.  Bode L (2013) Use of Human Milk Oligosaccharides and Infant Formula. Invited Speaker, International Scientific Association For Probiotics and Prebiotics and
The Sackler Institute for Nutrition Science at the New York Academy of Science, New York, NY, USA.

 

52.  Bode L (2013) Human Milk Oligosaccharides in the Prevention of Necrotizing Enterocolitis. Invited Speaker, American Academy of Pediatrics Perinatal Section, 82nd Perinatal & Developmental Medicine Symposium, Aspen, CO, USA.

 

51.  Bode L (2013) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, American Academy of Pediatrics Perinatal Section, 82nd Perinatal & Developmental Medicine Symposium, Aspen, CO, USA.

 

50.  Bode L (2013) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, 9th Annual Carbohydrate Symposium, Alberta Glycomics Centre, Banff, Canada.

 

49.  Bode L (2013) Human Milk Oligosaccharides: A Spoonful of Oligo-Sugar. Invited Speaker, Annual Dialogues in Neonatal-Perinatal Medicine Conference, Duke University Medical Center, Durham, NC, USA.

 

48.  Bode L (2013) Human Milk Oligosaccharides: Antimicrobials in the context of amebiasis, mother-to-child HIV transmission, and necrotizing enterocolitis. Invited Speaker, National Institutes of Health, Workshop on Bioactive Glycans in Human Milk, Bethesda, MD, USA.

 

47.  Bode L (2013) Human Milk Oligosaccharides: Two Short Stories and a Hairy Monster. Invited Speaker, Department of Pediatrics Faculty Research Symposium, UCSD / Rady Children’s Hospital, San Diego, CA, USA.

 

46.  Bode L (2013) Human Milk Oligosaccharides: An Update from the “Milk Gang. Invited Speaker, 16th Annual Glycobiology Symposium, Glycobiology Research and Training Center, San Diego, CA, USA.

 

45.  Bode L (2012) Human Milk Oligosaccharides: Why Glycans Matter. Invited Speaker, Research Seminar, Digestive Disease Center, Baylor College of Medicine, Houston, TX, USA.

 

44.  Bode L (2012) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, Research Seminar, Washington State University, School of Biological Sciences, Pullman, WA, USA.

 

43.  Bode L (2012) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, Research Seminar, Technical University Munich, Molecular Nutrition Department, Munich, Germany.

 

42.  Bode L (2012) The Role of Oligosaccharides in the Protection from NEC: Data from an Original Study. Invited Speaker, 16th Conference of the International Society for Research in Human Milk and Lactation, Trieste, Italy.

 

41.  Bode L (2012) Human Milk Oligosaccharides: Structure-Function Relationships in the Context of Infant Disease. Invited Speaker, 16th Conference of the International Society for Research in Human Milk and Lactation, Trieste, Italy.

 

40.  Bode L (2012) Human Milk Oligosaccharides and the Benefits for the Breastfed Infant. Invited Speaker, Seminar, World Breastfeeding Week, San Diego County Breastfeeding Coalition, San Diego, CA, USA.

 

39.  Bode L (2012) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, Grand Rounds, Rady Children’s Hospital San Diego, San Diego, CA, USA.

 

38.  Bode L (2012) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, 7th International Breastfeeding and Lactation Symposium, Vienna, Austria.

 

37.  Bode L (2012) Human Milk Oligosaccharides: A Research Update. Invited Speaker. 5th Annual Glycobiology Symposium, Glycobiology Research and Training Center, San Diego, CA, USA

 

36.  Bode L (2011) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, Pediatrics Faculty Research Seminar, UCSD Department of Pediatrics, San Diego, CA, USA.

 

35.  Bode L (2011) Human Milk Oligosaccharides: Every Baby Needs a Sugar Mama. Invited Speaker, Research Seminar, UCSD Department of Medicine, San Diego, CA, USA.

 

34.  Bode L (2011) Pre-, Pro-, Synbiotics and beyond. Invited Speaker, Neonatal and Pediatric Nutrition Conference: Update 2011, San Diego, CA. USA.

 

33.  Bode L (2011) All I need to know about Nutritional Science: for the Healthcare Professional. Invited Speaker, Neonatal and Pediatric Nutrition Conference: Update 2011, San Diego, CA. USA.

 

32.  Bode L (2011) Human Milk Oligosaccharides prevent Necrotizing Enterocolitis in Neonatal Rats. Invited Speaker, 44th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), Sorrento, Italy.

 

31.  Bode L (2011) Human Milk Oligosaccharides in Amebiasis and Necrotizing Enterocolitis. Invited Speaker, 1st International Conference on the Glycobiology of Human Milk Oligosaccharides, Copenhagen, Denmark.

 

30.  Bode L (2011) Human Milk Oligosaccharides. Invited Speaker, 5th Glycan Forum, Berlin, Germany.

 

29.  Bode L (2011) Human Milk Oligosaccharides: A Research Update.  Invited Speaker, 14th Annual Glycobiology Symposium, Glycobiology Research and Training Center, San Diego, CA, USA.

 

28.  Bode L (2010) Human Milk Oligosaccharides: Prebiotics and More. Invited Speaker, Neonatal and Pediatric Nutrition: Update 2010. San Diego, CA, USA.

 

27.  Bode L (2010) Nutrition Science Primer for the Healthcare Practitioner. Invited Speaker, Neonatal and Pediatric Nutrition: Update 2010. San Diego, CA, USA.

 

26.  Bode L (2010) Human Milk Oligosaccharides Prevent Necrotizing Enterocolitis in a Rat Model. Selected Speaker. Experimental Biology. Anaheim, CA, USA.

 

25.  Bode L (2010) Human Milk Oligosaccharides in the Prevention of Necrotizing Enterocolitis. Invited Speaker. Pediatric Grand Rounds. University of California, San Diego, CA, USA.

 

24.  Bode L (2010) Human Milk Oligosaccharides: A Research Perspective. Invited Speaker. Columbus, OH, USA.

 

23.  Bode L (2009) Human Milk Oligosaccharides prevent Necrotizing Enterocolitis in an animal model. Invited Speaker. Scripps Mercy Hospital, San Diego, CA, USA.

 

22.  Bode L (2009) Human Milk Oligosaccharides in the prevention of Childhood Diseases. Invited Speaker. Sanford Children’s Health Research Symposium. Sioux Falls, SD, USA.

 

21.  Bode L (2009) Human Milk Oligosaccharides. Invited Speaker. Sharp Mary Birch Hospital for Women, San Diego, CA, USA.

 

20.  Bode L (2009) Human milk oligosaccharides – Only the breast. Guest Speaker. Joint Fellows’ Neonatal Conference. TriCity Medical Center, CA, USA.

 

19.  Bode L (2009) Functions and Biosynthesis of Human Milk Oligosaccharides. Invited Speaker, San Diego Glycobiology Symposium, San Diego, CA, USA.

 

18.  Bode L (2008) Human milk oligosaccharides – Prebiotics and Beyond. Invited Speaker, Mexico City, Mexico.

 

17.  Bode L (2008) Human milk oligosaccharides – Biosynthesis, Functions, Clinical Implications. Invited Speaker, Research Seminar, Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern California, CA, USA.

 

16.  Bode L (2008) Human milk oligosaccharides: Can Mom’s sugars prevent Necrotizing Enterocolitis? Invited Speaker, Research Seminar, Gastroenterology Department, University of California San Diego, San Diego, CA, USA.

 

15.  Bode L (2008) Human milk oligosaccharides – Biosynthesis, Function, Clinical Implication. Invited Speaker, Research Seminar, Pediatrics Department, Neonatology Division, University of California San Diego, San Diego, CA, USA.

 

14.  Bode L (2007) Human milk oligosaccharides – Only the breast. Invited speaker, Research Seminar, University of California Davis, CA, USA.

 

13.  Bode L (2007) Human milk oligosaccharides – A Multidisciplinary Approach. Invited speaker, Philadelphia.

 

12.  Bode L (2006) Central role of heparan sulphate proteoglycans in preventing intestinal epithelial protein leakage. Lessons for the endothelial barrier? Invited speaker, 24th European Conference on Microcirculation. Amsterdam, the Netherlands.

 

11.  Bode L (2006) Protein losing enteropathy: from clinical observations to basic research; from basic research to clinical applications. Invited speaker, Gastrointestinal Research Seminar, University of California San Diego. San Diego, CA, USA.

 

10.  Bode L (2006) Inhibiting the signal before it strikes – Central role of heparan sulphate and heparan in pathogenesis and therapy of protein-losing enteropathy. Invited guest speaker, Signal Transduction Program Retreat. San Diego, CA, USA.

 

9.  Bode L, Park PW, Murch S, Freeze HH (2006) Loss of cell-associated heparan sulfate (HS) amplifies IFNγ- and TNFα-induced protein leakage in a model of Protein-Losing Enteropathy (PLE). Experimental Biology Meeting, San Francisco, CA, USA. 

 

8.  Bode L, Park PW, Murch S, Freeze HH (2005) Loss of cell-associated heparan sulfate amplifies IFNγ- and TNFα-induced protein leakage in a model of Protein-Losing Enteropathy. 16th Joint Meeting of Glycobiology, Hannover, Germany.

 

7.  Bode L, Salvestrini C, Murch S, Park PW, Linhardt RJ, Freeze HH (2005) Proposed molecular mechanisms of protein-losing enteropathy. Gordon Research Conference Glycobiology, Ventura, CA, USA.

 

6.  Bode L, Eklund EA, Salvestrini C, Murch S, Freeze HH (2004) An in vitro cellular model of protein- losing enteropathy implicates heparan sulfate, inflammatory cytokines, and hydrostatic pressure as critical players. ESPGHAN world meeting, Paris, France. Journal of Pediatric Gastroenterology and Nutrition 39: S59

 

5.  Bode L, Rudloff S, Kunz C, Strobel S, Klein N (2004) Human milk oligosaccharides reduce platelet- neutrophil complex formation and suppress neutrophil beta 2 integrin expression. Experimental Biology Meeting, Washington, DC, USA. The FASEB Journal 18: A843-4

 

4.  Bode L (2003) Human milk oligosaccharides as inhibitors of selectin-mediated cell-cell interactions. Invited speaker, scientific seminar, The Technical University of Denmark, BioCentrum-DTU, Section for Biochemistry and Nutrition, Lyngby, Denmark.

 

3.  Bode L, Rudloff S (2002) Einfluss von Humanmilch-Oligosacchariden auf die Adhäsion von Monozyten an Endothelzellen. [German] 39th Meeting of the German Nutrition Society, Jena, Germany. Proceedings of the German Nutrition Society 4: 17

 

2.  Bode L (2002) Effects of human milk oligosaccharides on leukocyte adhesion to endothelial cells. The Summer Course Glycoscience, Wageningen, the Netherlands

 

1.  Bode L, Rudloff S (2001) Mögliche systemische Effekte von Humanmilch Oligosacchariden (HMO)– Ein in vitro Modell. [German] 97th Meeting of the German Paediatric Society, Freiburg, Germany. Monatsschrift Kinderheilkunde 149: S132